We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Home » Industry Sees Patient Risks in UK Off-Label Guidance
Industry Sees Patient Risks in UK Off-Label Guidance
July 28, 2011
UK industry stakeholders are raising concerns over the General Medical Council’s (GMC) proposed guidance on prescribing off-label or unlicensed medical products. International Medical Device Regulatory Monitor
